NO20061207L - Karboksylsyreforbindelser og medisinske preparater inneholdende de samme som den aktive bestanddel - Google Patents
Karboksylsyreforbindelser og medisinske preparater inneholdende de samme som den aktive bestanddelInfo
- Publication number
- NO20061207L NO20061207L NO20061207A NO20061207A NO20061207L NO 20061207 L NO20061207 L NO 20061207L NO 20061207 A NO20061207 A NO 20061207A NO 20061207 A NO20061207 A NO 20061207A NO 20061207 L NO20061207 L NO 20061207L
- Authority
- NO
- Norway
- Prior art keywords
- itching
- receptors
- urticaria
- inflammation
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Nutrition Science (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Transplantation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003325198 | 2003-09-17 | ||
| JP2004101863 | 2004-03-31 | ||
| PCT/JP2004/013983 WO2005028455A1 (ja) | 2003-09-17 | 2004-09-16 | カルボン酸化合物およびそれらを有効成分として含有する医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061207L true NO20061207L (no) | 2006-06-19 |
Family
ID=34380314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061207A NO20061207L (no) | 2003-09-17 | 2006-03-15 | Karboksylsyreforbindelser og medisinske preparater inneholdende de samme som den aktive bestanddel |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7601712B2 (es) |
| EP (1) | EP1666473B1 (es) |
| JP (1) | JP4919143B2 (es) |
| KR (1) | KR20060080197A (es) |
| AU (1) | AU2004274324B2 (es) |
| BR (1) | BRPI0414487A (es) |
| CA (1) | CA2539070C (es) |
| DK (1) | DK1666473T3 (es) |
| ES (1) | ES2399393T3 (es) |
| IL (1) | IL174336A (es) |
| MX (1) | MXPA06002945A (es) |
| NO (1) | NO20061207L (es) |
| NZ (1) | NZ545934A (es) |
| PL (1) | PL1666473T3 (es) |
| PT (1) | PT1666473E (es) |
| RU (1) | RU2375353C2 (es) |
| TW (1) | TWI341838B (es) |
| WO (1) | WO2005028455A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004064817A1 (ja) * | 2003-01-22 | 2004-08-05 | Nichiban Co., Ltd. | 眼疾患治療用経皮吸収型製剤、その使用、及び眼疾患治療薬の眼の局所組織への移行方法 |
| DK2037967T3 (en) | 2006-06-16 | 2017-03-13 | Univ Pennsylvania | PROSTAGLANDIN-D2 RECEPTOR ANTAGONISTS FOR TREATMENT OF ANDROGENETIC ALOPECI |
| FR2903985B1 (fr) | 2006-07-24 | 2008-09-05 | Sanofi Aventis Sa | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| TWI410410B (zh) | 2007-08-10 | 2013-10-01 | Ono Pharmaceutical Co | Phenylacetic acid compounds |
| DE102008059133A1 (de) | 2008-11-26 | 2010-05-27 | Merck Patent Gmbh | Difluorphenyl-diacylhydrazid-derivate |
| WO2016001452A1 (en) | 2014-07-04 | 2016-01-07 | Universität Zürich | Compounds, in particular for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated |
| RU2626829C2 (ru) * | 2015-11-02 | 2017-08-02 | Анатолий Тимофеевич Корабельников | Средство для лечения полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения |
| KR20220107330A (ko) | 2018-09-20 | 2022-08-02 | 오노 야꾸힝 고교 가부시키가이샤 | Dp 길항제 |
| TW202146394A (zh) * | 2020-03-19 | 2021-12-16 | 日商小野藥品工業股份有限公司 | 苯乙酸化合物之結晶 |
| JP7047954B2 (ja) * | 2020-03-19 | 2022-04-05 | 小野薬品工業株式会社 | フェニル酢酸化合物を含有する医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5764655A (en) * | 1980-10-04 | 1982-04-19 | Nippon Zoki Pharmaceut Co Ltd | Novel benzoylaminophenylcarboxylic acid derivative, its preparation, and drug composition comprising it |
| WO1986005779A1 (en) * | 1985-04-03 | 1986-10-09 | Yamanouchi Pharmaceutical Co., Ltd. | Phenylene derivatives |
| RU2259998C2 (ru) * | 2000-03-09 | 2005-09-10 | Оно Фармасьютикал Ко., Лтд. | Производные индола, способ их получения и их применение |
| ATE516277T1 (de) * | 2002-03-19 | 2011-07-15 | Ono Pharmaceutical Co | Carbonsäureverbindungen und arzneimittel, die diese verbindungen als wirkstoffe enthalten |
| AU2003227325B2 (en) * | 2002-08-02 | 2009-05-28 | Scientific Games, Llc | Lottery ticket security method |
| KR20050106421A (ko) * | 2003-02-07 | 2005-11-09 | 오노 야꾸힝 고교 가부시키가이샤 | 카르복실산 화합물 |
| AU2004236248A1 (en) | 2003-04-30 | 2004-11-18 | The Institutes For Pharmaceutical Discovery, Llc | Phenyl substituted carboxylic acids |
-
2004
- 2004-09-16 PT PT47733738T patent/PT1666473E/pt unknown
- 2004-09-16 CA CA2539070A patent/CA2539070C/en not_active Expired - Fee Related
- 2004-09-16 US US10/572,578 patent/US7601712B2/en not_active Expired - Fee Related
- 2004-09-16 EP EP04773373A patent/EP1666473B1/en active Active
- 2004-09-16 AU AU2004274324A patent/AU2004274324B2/en not_active Ceased
- 2004-09-16 TW TW093127979A patent/TWI341838B/zh not_active IP Right Cessation
- 2004-09-16 MX MXPA06002945A patent/MXPA06002945A/es active IP Right Grant
- 2004-09-16 WO PCT/JP2004/013983 patent/WO2005028455A1/ja active Application Filing
- 2004-09-16 KR KR1020067005190A patent/KR20060080197A/ko not_active IP Right Cessation
- 2004-09-16 PL PL04773373T patent/PL1666473T3/pl unknown
- 2004-09-16 BR BRPI0414487-2A patent/BRPI0414487A/pt active Search and Examination
- 2004-09-16 RU RU2006112573/04A patent/RU2375353C2/ru not_active IP Right Cessation
- 2004-09-16 ES ES04773373T patent/ES2399393T3/es active Active
- 2004-09-16 DK DK04773373.8T patent/DK1666473T3/da active
- 2004-09-16 JP JP2005514124A patent/JP4919143B2/ja not_active Expired - Fee Related
- 2004-09-16 NZ NZ545934A patent/NZ545934A/en not_active IP Right Cessation
-
2006
- 2006-03-15 NO NO20061207A patent/NO20061207L/no not_active Application Discontinuation
- 2006-03-15 IL IL174336A patent/IL174336A/en not_active IP Right Cessation
-
2009
- 2009-09-01 US US12/551,860 patent/US8138335B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20070004716A1 (en) | 2007-01-04 |
| US7601712B2 (en) | 2009-10-13 |
| TWI341838B (en) | 2011-05-11 |
| MXPA06002945A (es) | 2006-06-14 |
| BRPI0414487A (pt) | 2006-11-14 |
| PL1666473T3 (pl) | 2013-05-31 |
| DK1666473T3 (da) | 2013-03-25 |
| AU2004274324B2 (en) | 2009-11-05 |
| EP1666473A1 (en) | 2006-06-07 |
| RU2006112573A (ru) | 2007-10-27 |
| US20100029631A1 (en) | 2010-02-04 |
| US8138335B2 (en) | 2012-03-20 |
| PT1666473E (pt) | 2013-02-15 |
| CA2539070A1 (en) | 2005-03-31 |
| KR20060080197A (ko) | 2006-07-07 |
| JPWO2005028455A1 (ja) | 2006-11-30 |
| EP1666473A4 (en) | 2009-06-03 |
| EP1666473B1 (en) | 2013-01-02 |
| CA2539070C (en) | 2011-12-13 |
| AU2004274324A1 (en) | 2005-03-31 |
| NZ545934A (en) | 2009-05-31 |
| IL174336A0 (en) | 2006-08-01 |
| RU2375353C2 (ru) | 2009-12-10 |
| ES2399393T3 (es) | 2013-04-01 |
| TW200524886A (en) | 2005-08-01 |
| IL174336A (en) | 2012-01-31 |
| JP4919143B2 (ja) | 2012-04-18 |
| WO2005028455A1 (ja) | 2005-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20061207L (no) | Karboksylsyreforbindelser og medisinske preparater inneholdende de samme som den aktive bestanddel | |
| NO20024281L (no) | Indolderivater, fremgangsmÕte for fremstilling av de samme og anvendelse derav | |
| NO20084291L (no) | 2,6-substituert-4-monosubstituert aminopyridin som prostaglandin D2 reseptor-antagonister | |
| NO20074336L (no) | 2-fenylindoler som prostaglandin D2 reseptorantagonister | |
| NO20090862L (no) | 2-fenyl-indoler som prostaglandin D2-reseptorantagonister | |
| WO2005021515A3 (en) | Inhibitors of phosphodiesterase type-iv | |
| UA88485C2 (en) | 2,6-substituted-4-monosubstituted amino-pyrimidines as prostaglandin d2 receptor antagonists | |
| WO2007047378A3 (en) | Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist | |
| WO2014037342A1 (de) | Herbizid wirksame bicycloarylcarbonsäureamide | |
| WO2006085212A3 (en) | Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv | |
| WO2006064355A3 (en) | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders | |
| NO20043894L (no) | Karboksysyreforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| EA200900472A1 (ru) | Ингибиторы фосфодиэстеразы iv типа | |
| TW200635932A (en) | New pyridothienopyrimidine derivatives | |
| NO20080457L (no) | Kjemiske forbindelser | |
| WO2010084402A3 (en) | Heterocyclic compounds as phosphodiesterase inhibitors | |
| WO2014086734A1 (de) | N-(oxazol-2-yl)-arylcarbonsäureamide und ihre verwendung als herbizide | |
| EP2844650A1 (de) | 6-pyridon-2-carbamoyl-azole und ihre verwendung als herbizide | |
| WO2005051931A3 (en) | Phosphodiesterase inhibitors | |
| WO2006129158A3 (en) | 3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i | |
| WO2015007633A1 (de) | 6-azinon-2-carbonyl-derivate und ihre verwendung als herbizide | |
| UA95303C2 (en) | 2-phenyl-indoles as prostaglandin d2 receptor antagonists | |
| TH106955A (th) | 2-เฟนิล-อินโดล ที่เป็นกลุ่มสารต้านตัวรับพรอสตาแกลนดิน d2 | |
| WO2007046022A3 (en) | Inhibitors of phosphodiesterase type-iv | |
| TH84867A (th) | สารประกอบเฮทเทอโรไซคลิคใหม่ที่เป็นประโยชน์สำหรับการรักษาความผิดปกติทางการอักเสบและทางด้านภูมิแพ้ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |